Amgen (AMGN) Depreciation & Amortization (CF) (2009 - 2026)

Amgen's Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 19.54% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $4.9 billion (down 12.26% YoY), while the FY2025 annual figure was $5.2 billion, down 7.6% from the prior year.
• Depreciation & Amortization (CF) was $1.1 billion for Q1 2026 at Amgen, down from $1.1 billion in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.4 billion in Q2 2024 to a low of $828.0 million in Q2 2022.
• Historically, Depreciation & Amortization (CF) has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2025.
• The sharpest annual moves came in 2024 and 2026: Depreciation & Amortization (CF) jumped 56.25% in 2024, then dropped 19.54% in 2026.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $911.0 million in 2022, then jumped by 51.48% to $1.4 billion in 2023, then rose by 1.23% to $1.4 billion in 2024, then declined by 18.97% to $1.1 billion in 2025, then declined by 1.41% to $1.1 billion in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.